Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Eating Disorders

 

Group Leader
Associate Professor Amanda Sainsbury-Salis

 
Group Leader
Professor Herbert Herzog

 

One of our laboratory's major goals is to understand how the brain, notably the hypothalamus, regulates appetite and body weight. Defects in the brain pathways that regulate these processes may be responsible for wasting conditions such as anorexia nervosa and cancer cachexia as well as the metabolic resistance to weight loss that often occurs when people try to shed excess weight (the ‘famine reaction’).

Our main focus is on neuropeptide Y (NPY) and its Y-receptors (Y1, Y2, Y4, Y5 and Y6), since many of the molecules that regulate appetite and body weight do so via interaction with the hypothalamic NPY-ergic system.

An intriguing finding in our research is that the very molecules that regulate body weight also regulate aggression, fertility as well as growth and development of lean body tissues such as muscle and bone. Therefore a second emphasis of our research is to understand how molecules in the hypothalamus influence moods and behaviour, fertility, growth, and immune system function. Our research findings have implications for the development of improved weight loss strategies, as well as novel treatments for infertility, poor lactation, dwarfism, osteoporosis (link to Paul Baldock’s group), anorexia nervosa and cancer cachexia.

Our lab has a number of conditional knockout and transgenic models that allow us to dissect the actions of signalling molecules such as dynorphins and neuropeptide Y on various cell types. Clinical collaborations allow us to collect patient data to test theories relating to modifying appetite and weight.


Staff

 

Shu LinSenior Research Officer
Dr Shu Lin
Nikki LeeResearch Officer
Dr Nikki Lee
Lei ZhangResearch Officer
Dr Lei Zhang
Yanchuan ShiResearch Officer
Dr Yanchuan Shi
Yue QiResearch Officer
Dr Yue Qi
Kazuhiko InoueVisiting Scientist
Dr Kazuhiko Inoue
Jennifer LeeResearch Assistant
Ms Jennifer Lee
Miyuki YagiVisiting Research Officer
Dr Miyuki Yagi
Jackie LauResearch Assistant
Ms Jackie Lau
Emma ZhangResearch Assistant
Ms Emma Zhang
Louise PurtellPhD Student
Ms Louise Purtell
Amy Nguyen 2PhD Student
Ms Amy Nguyen

Laura VahataloVisiting PhD Student
Ms Laura Vahatalo

 

News

 

Large NHMRC grant supports study of genes that affect appetite in flies, mice and humans

02 Nov 2011
Neuroscientists at Garvan have been awarded a $1,840,000 five-year project grant from Australia’s main medical research funding body, the National Health and Medical Research Council. Ranked within the top 3 out of 3,500 project applications, the study will screen the whole genome of the fruit fly, looking for genes that affect appetite and energy expenditure, which are also ‘conserved’ across species.
 
 

A powerful gut hormone that affects insulin and blood sugar levels

MEDIA RELEASE: 16 Jun 2010
Garvan researchers, in collaboration with English colleagues, have shown that a gut hormone released after we eat determines the speed at which we digest food and absorb nutrients across the gut into our blood. This makes it very influential in disorders such as Type 2 diabetes, and a promising therapeutic target.
 
 

New weight loss approach targets the body and not the brain

MEDIA RELEASE: 25 Nov 2009
Current drug-based weight loss therapies try to stop the brain from sending hunger signals to the body. These therapies tend to be fairly ineffective, Garvan researchers reasoned, so why not reverse the approach and stop the body from receiving signals from the brain? So that’s what they did, and it worked. In mice at least.
 
 

Personal tools